ABSTRACT:LeRoy Walters was at the center of public debate about emerging biological technologies, even as “biotechnology” began to take root. He chaired advisory panels on human gene therapy, the human genome project, and patenting DNA for the congressional Office of Technology Assessment. He chaired the subcommittee on Human Gene Therapy for NIH’s Recombinant DNA Advisory Committee. He was also a regular advisor to Congress, the executive branch, and academics concerned about policy governing emerging biotechnologies. In large part due to Prof. Walters, the Kennedy Institute of Ethics was one of the primary sources of talent in bioethics, including staff who populated policy and science agencies dealing with reproductive and genetic technologies, such as NIH and OTA. His legacy lies not only in his writings, but in those people, documents, and discussions that guided biotechnology policy in the United States for three decades.

中文翻译：

---

勒罗伊·沃尔特斯（LeRoy Walters）的遗传学和生物技术政策中的生命伦理学遗产。

摘要：尽管“生物技术”开始生根，但勒罗伊·沃尔特斯（LeRoy Walters）还是有关新兴生物技术的公开辩论的中心。他主持了有关人类基因治疗，人类基因组计划以及国会技术评估办公室DNA专利的咨询小组。他主持了NIH重组DNA咨询委员会人类基因治疗小组委员会的主席。他还是国会，行政部门和关注新兴生物技术政策的学者的定期顾问。很大程度上是由于沃尔特斯教授的缘故，肯尼迪伦理学研究所是生物伦理学人才的主要来源之一，其中包括从事生殖和遗传技术（如NIH和OTA）的政策和科学机构的人员。他的遗产不仅在于他的著作，而且在于那些人，文件，